Recent research has indicated that appetite-regulating hormones from the gut may have
therapeutic potential. The incretin hormone, glucagon-like peptide-1 (GLP-1), appears to be …

Over the past 50 years, many countries around the world have faced an unchecked
pandemic of obesity and type 2 diabetes (T2DM). As best practice treatment of T2DM has …

The purpose of this review is to evaluate the influence of bariatric surgery on the use and
pharmacokinetics of some frequently used drugs. A PubMed literature search was …

Introduction: Despite type 2 diabetes (T2D) management offers a variety of pharmacological
interventions targeting different defects, numerous patients remain with persistent …

Type 2 diabetes mellitus (T2D) is emerging as a worldwide public health problem, and is
mainly associated with an increased incidence of obesity. Bariatric surgery is currently …

Introduction: Novelties in the management of type 2 diabetes are dominated by the
commercialisation of new glucose-lowering agents, which offer alternatives to older …

Type 2 diabetes mellitus (T2DM) is a global public health problem often associated with
obesity. Bariatric surgery is effective for treating serious obesity, and techniques involving …

Background The safety and efficacy of laparoscopic sleeve gastrectomy (LSG) and
laparoscopic Roux-en-Y gastric bypass (LRYGB) to treat obesity and associated …

Background Although medium-to long-term improvement in insulin resistance and T2DM
after Roux-en-Y gastric bypass (RYGB) is well documented, few studies have analyzed the …

BACKGROUND: Type 2 diabetes mellitus is highly prevalent in obese individuals. Bariatric
surgery, promoted for reducing the medical problems of morbid obesity, has been …